-
Je něco špatně v tomto záznamu ?
Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing
Z. Chyra Kufova, T. Sevcikova, J. Januska, P. Vojta, A. Boday, P. Vanickova, J. Filipova, K. Growkova, T. Jelinek, M. Hajduch, R. Hajek,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
Grantová podpora
NV15-29667A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
ProQuest Central
od 2000-01-01 do Před 6 měsíci
Health & Medicine (ProQuest)
od 2000-01-01 do Před 6 měsíci
- MeSH
- dospělí MeSH
- familiární amyloidóza diagnóza genetika MeSH
- fenotyp MeSH
- frekvence genu MeSH
- genetická predispozice k nemoci MeSH
- genetické markery MeSH
- hypertrofická kardiomyopatie diagnóza genetika MeSH
- jednonukleotidový polymorfismus * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mutace * MeSH
- mutační analýza DNA metody MeSH
- pilotní projekty MeSH
- prediktivní hodnota testů MeSH
- reprodukovatelnost výsledků MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- stanovení celkové genové exprese metody MeSH
- transkriptom * MeSH
- výpočetní biologie MeSH
- vysoce účinné nukleotidové sekvenování * MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
AIMS: Amyloidosis is caused by deposition of abnormal protein fibrils, leading to damage of organ function. Hereditary amyloidosis represents a monogenic disease caused by germline mutations in 11 amyloidogenic precursor protein genes. One of the important but non-specific symptoms of amyloidosis is hypertrophic cardiomyopathy. Diagnostics of hereditary amyloidosis is complicated and the real cause can remain overlooked. We aimed to design hereditary amyloidosis gene panel and to introduce new next-generation sequencing (NGS) approach to investigate hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance. METHODS: Design of target enrichment DNA library preparation using Haloplex Custom Kit containing 11 amyloidogenic genes was followed by MiSeq Illumina sequencing and bioinformatics identification of germline variants using tool VarScan in a cohort of 40 patients. RESULTS: We present design of NGS panel for 11 genes (TTR, FGA, APOA1, APOA2, LYZ, GSN, CST3, PRNP, APP, B2M, ITM2B) connected to various forms of amyloidosis. We detected one mutation, which is responsible for hereditary amyloidosis. Some other single nucleotide variants are so far undescribed or rare variants or represent common polymorphisms in European population. CONCLUSIONS: We report one positive case of hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance and set up first panel for NGS in hereditary amyloidosis. This work may facilitate successful implementation of the NGS method by other researchers or clinicians and may improve the diagnostic process after validation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033305
- 003
- CZ-PrNML
- 005
- 20240725141657.0
- 007
- ta
- 008
- 181008s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/jclinpath-2017-204978 $2 doi
- 035 __
- $a (PubMed)29455155
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Chyra Kufova, Zuzana $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
- 245 10
- $a Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing / $c Z. Chyra Kufova, T. Sevcikova, J. Januska, P. Vojta, A. Boday, P. Vanickova, J. Filipova, K. Growkova, T. Jelinek, M. Hajduch, R. Hajek,
- 520 9_
- $a AIMS: Amyloidosis is caused by deposition of abnormal protein fibrils, leading to damage of organ function. Hereditary amyloidosis represents a monogenic disease caused by germline mutations in 11 amyloidogenic precursor protein genes. One of the important but non-specific symptoms of amyloidosis is hypertrophic cardiomyopathy. Diagnostics of hereditary amyloidosis is complicated and the real cause can remain overlooked. We aimed to design hereditary amyloidosis gene panel and to introduce new next-generation sequencing (NGS) approach to investigate hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance. METHODS: Design of target enrichment DNA library preparation using Haloplex Custom Kit containing 11 amyloidogenic genes was followed by MiSeq Illumina sequencing and bioinformatics identification of germline variants using tool VarScan in a cohort of 40 patients. RESULTS: We present design of NGS panel for 11 genes (TTR, FGA, APOA1, APOA2, LYZ, GSN, CST3, PRNP, APP, B2M, ITM2B) connected to various forms of amyloidosis. We detected one mutation, which is responsible for hereditary amyloidosis. Some other single nucleotide variants are so far undescribed or rare variants or represent common polymorphisms in European population. CONCLUSIONS: We report one positive case of hereditary amyloidosis in a cohort of patients with hypertrophic cardiomyopathy of unknown significance and set up first panel for NGS in hereditary amyloidosis. This work may facilitate successful implementation of the NGS method by other researchers or clinicians and may improve the diagnostic process after validation.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a familiární amyloidóza $x diagnóza $x genetika $7 D028226
- 650 _2
- $a hypertrofická kardiomyopatie $x diagnóza $x genetika $7 D002312
- 650 _2
- $a výpočetní biologie $7 D019295
- 650 _2
- $a Česká republika $7 D018153
- 650 _2
- $a mutační analýza DNA $x metody $7 D004252
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a stanovení celkové genové exprese $x metody $7 D020869
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a genetické markery $7 D005819
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 12
- $a vysoce účinné nukleotidové sekvenování $7 D059014
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a fenotyp $7 D010641
- 650 _2
- $a pilotní projekty $7 D010865
- 650 12
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a rizikové faktory $7 D012307
- 650 12
- $a transkriptom $7 D059467
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sevcikova, Tereza $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Januska, Jaroslav $u Cardiocentre Podlesi, Trinec, Czech Republic.
- 700 1_
- $a Vojta, Petr $u Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic.
- 700 1_
- $a Boday, Arpad $u Laboratory of Molecular Biology, Department of Medical Genetics, Laboratory AGEL, Novy Jicin, Czech Republic.
- 700 1_
- $a Vanickova, Pavla $u Laboratory of Molecular Biology, Department of Medical Genetics, Laboratory AGEL, Novy Jicin, Czech Republic.
- 700 1_
- $a Filipová, Jana $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic. $7 xx0320621
- 700 1_
- $a Growkova, Katerina $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Jelínek, Tomáš, $d 1986- $7 xx0230997 $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic. Department of Biology and Ecology, Faculty of Science, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Hajduch, Marian $u Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic.
- 700 1_
- $a Hajek, Roman $u Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic. Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 773 0_
- $w MED00002597 $t Journal of clinical pathology $x 1472-4146 $g Roč. 71, č. 8 (2018), s. 687-694
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29455155 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20240725141651 $b ABA008
- 999 __
- $a ok $b bmc $g 1340096 $s 1030299
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 71 $c 8 $d 687-694 $e 20180217 $i 1472-4146 $m Journal of clinical pathology $n J Clin Pathol $x MED00002597
- GRA __
- $a NV15-29667A $p MZ0
- LZP __
- $a Pubmed-20181008